Arrowhead Pharmaceuticals (ARWR) Drug Pipeline
0 Followers
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Arrowhead Pharmaceuticals, Inc. (MX:ARWR) have in its pipeline
Arrowhead Pharmaceuticals MX:ARWR is currently developing the following drugs: Aro-033, Zodasiran, Aro-Ang3, Aro-Rage, Aro-Dimerpa, Aro-Mapt-Sc, Zodasiran Injection, Aro-Alk7, Plozasiran, Plozasiran Injection, Tirzepatide, Aro-Inhbe, Aro-Atxn2 Injection, Aro-Cfb, Aro-Dm1 For Injection, Aro-Dux4 For Injection, Vsa001 Injection, Aro-Mmp7 Inhalation Solution, Aro-Apoc3, Aro-Muc5ac, Aro-Ang 3 Injection, Aro-C3, Aro-Ang3, Aro-Enac, Sterile Normal Saline, Aro-Hsd Injection, Aro-Hif2, Fazisiran Injection, Aro-Aat, Sterile Normal Saline, Aro-Hbv, Jnj-56136379. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
